Natural Killer cells dampen the pathogenic features of recall responses to influenza infection
File(s)fimmu-11-00135.pdf (4.44 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Despite evidence of augmented Natural Killer (NK) cell responses after influenza vaccination, the role of these cells in vaccine-induced immunity remains unclear. Here, we hypothesized that NK cells might increase viral clearance but possibly at the expense of increased severity of pathology. On the contrary, we found that NK cells serve a homeostatic role during influenza virus infection of vaccinated mice, allowing viral clearance with minimal pathology. Using a diphtheria toxin receptor transgenic mouse model, we were able to specifically deplete NKp46+ NK cells through the administration of diphtheria toxin. Using this model, we assessed the effect of NK cell depletion prior to influenza challenge in vaccinated and unvaccinated mice. NK-depleted, vaccinated animals lost significantly more weight after viral challenge than vaccinated NK intact animals, indicating that NK cells ameliorate disease in vaccinated animals. However, there was also a significant reduction in viral load in NK-depleted, unvaccinated animals indicating that NK cells also constrain viral clearance. Depletion of NK cells after vaccination, but 21 days before infection, did not affect viral clearance or weight loss—indicating that it is the presence of NK cells during the infection itself that promotes homeostasis. Further work is needed to identify the mechanism(s) by which NK cells regulate adaptive immunity in influenza-vaccinated animals to allow efficient and effective virus control whilst simultaneously minimizing inflammation and pathology.
Date Issued
2020-02-07
Date Acceptance
2020-01-20
Citation
Frontiers in Immunology, 2020, 11, pp.1-14
ISSN
1664-3224
Publisher
Frontiers Media
Start Page
1
End Page
14
Journal / Book Title
Frontiers in Immunology
Volume
11
Copyright Statement
© 2020 Mooney, Qendro, Keith, Philbey, Groves, Tregoning, Goodier and Riley. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Identifier
https://www.frontiersin.org/articles/10.3389/fimmu.2020.00135/full
Subjects
1107 Immunology
1108 Medical Microbiology
Publication Status
Published
Article Number
135
Date Publish Online
2020-02-07